avapro has been researched along with Alport Syndrome in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishida, M | 1 |
| Hashimoto, F | 1 |
| Kaito, H | 1 |
| Nozu, K | 1 |
| Iijima, K | 1 |
| Asada, D | 1 |
| Hamaoka, K | 1 |
1 other study available for avapro and Alport Syndrome
| Article | Year |
|---|---|
Combined Alport syndrome and Klinefelter syndrome.
Topics: Angiotensin Receptor Antagonists; Biphenyl Compounds; Collagen Type IV; Humans; Infant; Irbesartan; | 2016 |